Yelena Janjigian and Norah Lewin Join NBC's Saturday TODAY to Discuss Cycle for Survival's 20th Anniversary

Global Partners Unite to Fund High-Risk, High-Reward Cancer Science - Cancer Grand Challenges

The One Vaccine That Could Save a Generation of Indian Women

Prof. Gevorg Tamamyan Joins the London Global Cancer Week Steering Group

Marty Makary: Approved a MM Drug Just 55 Days After the Application Was Filed

SURE-02 Trial: Neoadjuvant Sacituzumab Govitecan + Pembrolizumab in Muscle-Invasive Bladder Cancer

CART19-BE-02 trial: From Bench to Bedside and Beyond - Resonance

$1M AI Accelerator Grant for Ovarian Cancer Research - Ovarian Cancer Research Alliance

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

Khorana Score (Cancer-Associated VTE Risk)

Estimate VTE risk in ambulatory cancer patients using the validated Khorana score.

Khorana Score Points:

  • Very high-risk site (Stomach, Pancreas): +2
  • High-risk site (Lung, Lymphoma, Gynecologic, Bladder, Testicular): +1
  • Platelets ≥350 ×10⁹/L: +1
  • Hemoglobin <10 g/dL or ESA use: +1
  • WBC >11 ×10⁹/L: +1
  • BMI ≥35 kg/m²: +1

Risk Categories:

  • Low risk: 0 points
  • Intermediate risk: 1-2 points
  • High risk: ≥3 points